España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Janux Therapeutics
JANX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$56.83
0.08
0.14%
At close: -
$56.83
0.00
0.00%
After Hours: Dec 20, 4:04 PM EDT
Get Report
Comment
Janux Therapeutics (JANX) Forecast
News
Earnings
Janux Therapeutics (JANX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Janux Therapeutics (NASDAQ:JANX) Stock
Janux Therapeutics Stock (NASDAQ: JANX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 11, 2024
Navigating 10 Analyst Ratings For Janux Therapeutics
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Sunday, December 08, 2024
SoundHound, Asana And Victorias Secret Are Among Top 10 Mid Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?
Lekha Gupta
Thursday, December 05, 2024
Reported Earlier, Janux Therapeutics Prices $...
Benzinga Newsdesk
Wednesday, December 04, 2024
Janux Therapeutics shares are trading higher ...
Benzinga Newsdesk
Scotiabank Maintains Sector Perform on Janux ...
Benzinga Newsdesk
Tuesday, December 03, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Janux Therapeutics Commences Underwritten Pub...
Benzinga Newsdesk
Stifel Maintains Buy on Janux Therapeutics, R...
Benzinga Newsdesk
Leerink Partners Maintains Outperform on Janu...
Benzinga Newsdesk
Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst
Vandana Singh
AT&T Updates 2024 Outlook, Joins ZJK Industrial, Janux Therapeutics, Credo Technology Group And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Janux Therapeutics shares are trading higher ...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Janux Th...
Benzinga Newsdesk
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, December 02, 2024
Janux shares are trading higher after it anno...
Benzinga Newsdesk
Janux Announced Updated Interim Clinical Data...
Benzinga Newsdesk
Monday, November 25, 2024
Janux Therapeutics To Host Virtual Event On M...
Benzinga Newsdesk
Friday, November 22, 2024
Evaluating Janux Therapeutics: Insights From 6 Financial Analysts
Benzinga Insights
Leerink Partners Initiates Coverage On Janux ...
Benzinga Newsdesk
Tuesday, November 12, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Thursday, November 07, 2024
HC Wainwright & Co. Reiterates Buy on Janux T...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Wednesday, November 06, 2024
Janux Therapeutics Q3 EPS $(0.51) Misses $(0....
Benzinga Newsdesk
Thursday, October 24, 2024
Cracking The Code: Understanding Analyst Reviews For Janux Therapeutics
Benzinga Insights
UBS Initiates Coverage On Janux Therapeutics ...
Benzinga Newsdesk
Monday, September 16, 2024
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Friday, September 06, 2024
Navigating 5 Analyst Ratings For Janux Therapeutics
Benzinga Insights
Stifel Initiates Coverage On Janux Therapeuti...
Benzinga Newsdesk
Monday, August 19, 2024
HC Wainwright & Co. Reiterates Buy on Janux T...
Benzinga Newsdesk
Friday, August 09, 2024
Analyst Expectations For Janux Therapeutics's Future
Benzinga Insights
Scotiabank Maintains Sector Perform on Janux ...
Benzinga Newsdesk
Thursday, August 08, 2024
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Janux Therap...
Benzinga Newsdesk
Wednesday, August 07, 2024
Janux Therapeutics Q2 EPS $(0.11) Beats $(0.3...
Benzinga Newsdesk
Friday, August 02, 2024
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing (CORRECTED)
Michael Juliano
Monday, July 22, 2024
Janux Therapeutics Reports Appointment Of Cur...
Benzinga Newsdesk
Tuesday, July 16, 2024
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Friday, May 31, 2024
Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Thursday, May 30, 2024
The Latest Analyst Ratings For Janux Therapeutics
Benzinga Insights
Scotiabank Initiates Coverage On Janux Therap...
Benzinga Newsdesk
Monday, May 13, 2024
Analyst Ratings For Janux Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Janux Th...
Benzinga Newsdesk
Thursday, May 09, 2024
Janux Therapeutics shares are trading lower a...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Wednesday, May 08, 2024
Janux Therapeutics shares are trading lower a...
Benzinga Newsdesk
Janux Therapeutics Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
Wedbush Maintains Outperform on Janux Therape...
Benzinga Newsdesk
Janux Therapeutics Inc Files For Mixed Shelf;...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch